Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Rentokil Initial ADR | RTO | Jan 13, 2025 | 23.93 | +2.13 |
Repare Therapeutics | RPTX | Jan 13, 2025 | 1.31 | -5.07 |
Repay A | RPAY | Jan 13, 2025 | 7.30 | +0.69 |
Repligen | RGEN | Jan 13, 2025 | 158.44 | +2.31 |
Replimune Group | REPL | Jan 13, 2025 | 10.89 | -1.54 |
ReposiTrak | TRAK | Jan 13, 2025 | 20.54 | -0.87 |
Republic Bancorp A | RBCAA | Jan 13, 2025 | 65.11 | +0.48 |
Republic Services | RSG | Jan 13, 2025 | 207.22 | +0.45 |
Research Frontiers | REFR | Jan 13, 2025 | 1.64 | -2.96 |
Research Solutions | RSSS | Jan 13, 2025 | 3.84 | -5.19 |
Reservoir Media | RSVR | Jan 13, 2025 | 7.77 | -1.89 |
ReShape Lifesciences | RSLS | Jan 13, 2025 | 5.00 | +11.11 |
Resideo Technologies | REZI | Jan 13, 2025 | 22.10 | +0.55 |
ResMed | RMD | Jan 13, 2025 | 230.26 | -1.52 |
Resources Connection | RGP | Jan 13, 2025 | 8.45 | +1.20 |
Restaurant Brands International | QSR | Jan 13, 2025 | 60.94 | +0.10 |
Retail Bull 3X Direxion | RETL | Jan 13, 2025 | 9.36 | -3.01 |
Retail ETF Market Vectors | RTH | Jan 13, 2025 | 226.14 | -0.03 |
Retail Opportunity Investments | ROIC | Jan 13, 2025 | 17.36 | +0.06 |
ReTo Eco-Solutions | RETO | Jan 13, 2025 | 0.88 | -2.22 |
Retractable Technologies | RVP | Jan 13, 2025 | 0.75 | +2.00 |
REV Group | REVG | Jan 13, 2025 | 32.02 | -1.51 |
Revance Therapeutics | RVNC | Jan 13, 2025 | 3.29 | +1.23 |
Revelation Biosciences | REVB | Jan 13, 2025 | 0.50 | -5.47 |
Revelyst | GEAR | Jan 13, 2025 | 20.08 | 0.00 |
Revenueshares Largecap | RWL | Jan 13, 2025 | 98.78 | +0.66 |
Revenueshares Midcap | RWK | Jan 13, 2025 | 117.16 | +0.75 |
Revenueshares Smallcap | RWJ | Jan 13, 2025 | 45.12 | +0.51 |
Revenueshares Ultra Dividend Fund | RDIV | Jan 13, 2025 | 47.73 | +0.96 |
Reviva Pharmaceuticals | RVPH | Jan 13, 2025 | 1.91 | +1.60 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.